TGFBI and colorectal cancer: Our findings elucidate the molecular mechanism by which curcumol exerts its anti-metastatic effects through the regulation of the OTUB1/TGFBI axis, highlighting its potential as a novel therapeutic agent for colorectal cancer treatment.